| |
siRNA Id: | aspsirna3302
|
siRNA Name: | miSNP67T-1
|
Gene: | Hungtintin (HTT) |
Disease: | Huntington disease (HD) |
Wild allele/target (5'->3'): | CCGGAGCCUUUGGAAGUCUGC
|
Mutant allele/target (5'->3'): | CCGGAGCCUUUGGAAGUCUGU
|
Target Mutation: | NM_002111.6:c.9810C>T
|
Wild siRNA (As strand): | GGCCUCGGAAACCUUCAGACG
|
ASP-siRNA (As strand): | GGCCUCGGAAACCUUCAGACA
|
Mismatch position in siRNA: | A21G |
Mutant allele (5'->3'): | CCGGAGCCUUUGGAAGUCUGU
|
ASP-siRNA (As strand): | GGCCUCGGAAACCUUCAGACA
|
ASP-siRNA efficacy for mutant allele: | 15
|
Wild allele (5'->3'): | CCGGAGCCUUUGGAAGUCUGC
|
ASP-siRNA (As strand): | GGCCUCGGAAACCUUCAGACA
|
ASP-siRNA efficacy for wild allele: | 0
|
Percentage discrimination for ASP-siRNA: | 15
|
Wild allele (5'->3'): | CCGGAGCCUUUGGAAGUCUGC
|
Wild siRNA (As strand): | GGCCUCGGAAACCUUCAGACG
|
Wild sirna efficacy for wild allele: | 55
|
Wild allele (5'->3'): | CCGGAGCCUUUGGAAGUCUGC
|
ASP-siRNA (As strand): | GGCCUCGGAAACCUUCAGACA
|
Wild sirna efficacy for mutant allele: | 100
|
Percentage discrimination for wild siRNA: | -45
|
Concentration: | 50 ng |
Orientation: | Antisense |
Mismatch in: | siRNA |
UniProt ID: | Q96CV9 |
Target sequence: | AGGCGGCAGCTGGGGCCGGAGCCTTTGGAAGTCTGCGCCCTTG |
Genbank Accesion: | NM_002111.7 |
Cell-line: | HEK293T |
Experimental technique used: | Dual luciferase reporter assay |
Transfection method: | Lipofectamine 2000 |
siRNA expression method: | Chemically synthesized |
Post-transfection duration: | 48 hours |
OMID ID: | 143100 |
KEGG disease ID: | H00059 |
Reference: | 27003755 |